Company news
Shilpa Medicare Limited news in 2025
Shilpa Medicare Limited's news releases, calls and decks from 2025, newest first.
Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices
November 11, 2025
Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ -- A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV)
November 11, 2025
Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide
August 14, 2025
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
August 4, 2025
Decks in 2025
- Q2 FY26 Earnings Presentation
Earnings · 35 slides · Nov 13, 2025
- Q1 FY2026 Earnings Presentation
Earnings · 32 slides · Aug 13, 2025
- Q4 FY2025 Earnings Presentation
Earnings · 35 slides · May 26, 2025
- Q3 FY2025 Earnings Presentation
Earnings · 30 slides · Feb 10, 2025